The global sildenafil citrate market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing awareness about erectile dysfunction and its treatment, growing geriatric population, and rising prevalence of cardiovascular diseases. However, high cost of the drug may hamper the growth of this market in some regions. The global sildenafil citrate market is segmented on the basis of type into purity greater than or equal to 99% and purity below 99%. The purity greater than or equal to 99% segment accounted for a larger share in 2018 owing to its higher efficacy rates as compared with other types. The purity below 99% segment accounted for a smaller share in 2018 due to its lower efficacy rates as compared with other types. On the basis of application, the global sildenafil citrate market is divided into angina pectoris, erectile dysfunction (ED), and pulmonary hypertension (PH). In 2018, ED was estimated to account for a larger share owing to increasing awareness about ED among people across different age groups and rising prevalence among men aged 40-70 years old globally. PH was estimated to account for a smaller share due primarily due lack of awareness about PH among people across different age groups globally which may hamper growth prospects over time. -It works by inhibiting an enzyme called phosphodiesterase type 5 (PDE5) which is responsible for breaking down cGMP, a chemical that relaxes muscles and increases blood flow to the penis during sexual stimulation. -The drug has been shown to be effective in treating erectile dysfunction, but it does not cure the condition or reverse any physical changes caused by the condition.
Industry Growth Insights published a new data on “Sildenafil Citrate Market”. The research report is titled “Sildenafil Citrate Market research by Types (Purity Greater than or equal to99%, PurityBelow99%), By Applications (Angina Pectoris, Erectile Dysfunction, Pulmonary Hypertension, Other), By Players/Companies Rakshit, Bioindustria L.I.M., Polpharma, Biophore, Century Pharmaceuticals, Hebei Changshan Biochemical Pharmaceutical, Baiyunshan Pharmaceutical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sildenafil Citrate Market Research Report
By Type
Purity Greater than or equal to99%, PurityBelow99%
By Application
Angina Pectoris, Erectile Dysfunction, Pulmonary Hypertension, Other
By Companies
Rakshit, Bioindustria L.I.M., Polpharma, Biophore, Century Pharmaceuticals, Hebei Changshan Biochemical Pharmaceutical, Baiyunshan Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Sildenafil Citrate Market Report Segments:
The global Sildenafil Citrate market is segmented on the basis of:
Types
Purity Greater than or equal to99%, PurityBelow99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Angina Pectoris, Erectile Dysfunction, Pulmonary Hypertension, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Rakshit
- Bioindustria L.I.M.
- Polpharma
- Biophore
- Century Pharmaceuticals
- Hebei Changshan Biochemical Pharmaceutical
- Baiyunshan Pharmaceutical
Highlights of The Sildenafil Citrate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity Greater than or equal to99%
- PurityBelow99%
- By Application:
- Angina Pectoris
- Erectile Dysfunction
- Pulmonary Hypertension
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sildenafil Citrate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sildenafil Citrate is a medication used to treat erectile dysfunction (ED). It works by increasing blood flow to the penis.
Some of the major players in the sildenafil citrate market are Rakshit, Bioindustria L.I.M., Polpharma, Biophore, Century Pharmaceuticals, Hebei Changshan Biochemical Pharmaceutical, Baiyunshan Pharmaceutical.
The sildenafil citrate market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sildenafil Citrate Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sildenafil Citrate Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sildenafil Citrate Market - Supply Chain
4.5. Global Sildenafil Citrate Market Forecast
4.5.1. Sildenafil Citrate Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sildenafil Citrate Market Size (000 Units) and Y-o-Y Growth
4.5.3. Sildenafil Citrate Market Absolute $ Opportunity
5. Global Sildenafil Citrate Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Sildenafil Citrate Market Size and Volume Forecast by Type
5.3.1. Purity Greater than or equal to99%
5.3.2. PurityBelow99%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Sildenafil Citrate Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Sildenafil Citrate Market Size and Volume Forecast by Application
6.3.1. Angina Pectoris
6.3.2. Erectile Dysfunction
6.3.3. Pulmonary Hypertension
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Sildenafil Citrate Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Sildenafil Citrate Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Sildenafil Citrate Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sildenafil Citrate Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sildenafil Citrate Demand Share Forecast, 2019-2026
9. North America Sildenafil Citrate Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sildenafil Citrate Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sildenafil Citrate Market Size and Volume Forecast by Application
9.4.1. Angina Pectoris
9.4.2. Erectile Dysfunction
9.4.3. Pulmonary Hypertension
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Sildenafil Citrate Market Size and Volume Forecast by Type
9.7.1. Purity Greater than or equal to99%
9.7.2. PurityBelow99%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Sildenafil Citrate Demand Share Forecast, 2019-2026
10. Latin America Sildenafil Citrate Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sildenafil Citrate Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sildenafil Citrate Market Size and Volume Forecast by Application
10.4.1. Angina Pectoris
10.4.2. Erectile Dysfunction
10.4.3. Pulmonary Hypertension
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Sildenafil Citrate Market Size and Volume Forecast by Type
10.7.1. Purity Greater than or equal to99%
10.7.2. PurityBelow99%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Sildenafil Citrate Demand Share Forecast, 2019-2026
11. Europe Sildenafil Citrate Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sildenafil Citrate Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sildenafil Citrate Market Size and Volume Forecast by Application
11.4.1. Angina Pectoris
11.4.2. Erectile Dysfunction
11.4.3. Pulmonary Hypertension
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Sildenafil Citrate Market Size and Volume Forecast by Type
11.7.1. Purity Greater than or equal to99%
11.7.2. PurityBelow99%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projetions by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Sildenafil Citrate Demand Share, 2019-2026
12. Asia Pacific Sildenafil Citrate Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sildenafil Citrate Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sildenafil Citrate Market Size and Volume Forecast by Application
12.4.1. Angina Pectoris
12.4.2. Erectile Dysfunction
12.4.3. Pulmonary Hypertension
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Sildenafil Citrate Market Size and Volume Forecast by Type
12.7.1. Purity Greater than or equal to99%
12.7.2. PurityBelow99%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Sildenafil Citrate Demand Share, 2019-2026
13. Middle East & Africa Sildenafil Citrate Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Sildenafil Citrate Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sildenafil Citrate Market Size and Volume Forecast by Application
13.4.1. Angina Pectoris
13.4.2. Erectile Dysfunction
13.4.3. Pulmonary Hypertension
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Sildenafil Citrate Market Size and Volume Forecast by Type
13.7.1. Purity Greater than or equal to99%
13.7.2. PurityBelow99%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Sildenafil Citrate Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Sildenafil Citrate Market: Market Share Analysis
14.2. Sildenafil Citrate Distributors and Customers
14.3. Sildenafil Citrate Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Rakshit
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bioindustria L.I.M.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Polpharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biophore
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Century Pharmaceuticals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Hebei Changshan Biochemical Pharmaceutical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Baiyunshan Pharmaceutical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook